LLY

1,015.09

-0.37%↓

JNJ

245.52

+0.74%↑

ABBV

224.3

-0.98%↓

NVS

163.06

-1.25%↓

MRK

121.34

+0.52%↑

LLY

1,015.09

-0.37%↓

JNJ

245.52

+0.74%↑

ABBV

224.3

-0.98%↓

NVS

163.06

-1.25%↓

MRK

121.34

+0.52%↑

LLY

1,015.09

-0.37%↓

JNJ

245.52

+0.74%↑

ABBV

224.3

-0.98%↓

NVS

163.06

-1.25%↓

MRK

121.34

+0.52%↑

LLY

1,015.09

-0.37%↓

JNJ

245.52

+0.74%↑

ABBV

224.3

-0.98%↓

NVS

163.06

-1.25%↓

MRK

121.34

+0.52%↑

LLY

1,015.09

-0.37%↓

JNJ

245.52

+0.74%↑

ABBV

224.3

-0.98%↓

NVS

163.06

-1.25%↓

MRK

121.34

+0.52%↑

Search

Evolent Health Inc

Open

SectorHealthcare

2.67 -2.91

Overview

Share price change

24h

Current

Min

2.65

Max

2.8

Key metrics

By Trading Economics

Income

30M

-21M

Sales

35M

480M

Profit margin

-4.351

Employees

4,500

EBITDA

512K

15M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+187.77% upside

Dividends

By Dow Jones

Next Earnings

24 Feb 2026

Market Stats

By TradingEconomics

Market Cap

-456M

324M

Previous open

5.58

Previous close

2.67

News Sentiment

By Acuity

63%

37%

309 / 351 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bullish Evidence

Evolent Health Inc Chart

Past performance is not a reliable indicator of future results.

Related News

18 Feb 2026, 22:31 UTC

Earnings

Brambles Raises Dividend, Cash-Flow Guidance as 1st Half Profit Jumps -- Update

18 Feb 2026, 22:18 UTC

Earnings

Wal-Mart de Mexico 4Q Profit Falls, Hit by Higher Taxes

18 Feb 2026, 22:11 UTC

Earnings

Wesfarmers Boosts Dividend After 1st Half Profit Rises -- Update

18 Feb 2026, 21:52 UTC

Earnings

Telstra Boosts Dividend as First-Half Earnings Rise 5.5% -- Update

18 Feb 2026, 23:56 UTC

Market Talk

Santos's Review of Domestic Assets Could Lead to Simpler Portfolio -- Market Talk

18 Feb 2026, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

18 Feb 2026, 23:46 UTC

Market Talk

Nikkei May Rise After U.S. Tech Stock Gains -- Market Talk

18 Feb 2026, 23:34 UTC

Market Talk
Earnings

Brambles' Cost Control Stands Out to Bull -- Market Talk

18 Feb 2026, 23:33 UTC

Market Talk

Gold Edges Higher Amid Growing Risks of U.S.-Iran Conflict -- Market Talk

18 Feb 2026, 23:32 UTC

Market Talk

Australia Jobs Data Will Likely Support May Hike Assumptions -- Market Talk

18 Feb 2026, 22:45 UTC

Earnings

DoorDash Stock Rebounds. Earnings and Revenue Both Fall Short. -- Barrons.com

18 Feb 2026, 22:44 UTC

Market Talk

Investors Eyeing Nvidia's Revenue Visibility Ahead of 4Q Print -- Market Talk

18 Feb 2026, 22:37 UTC

Earnings

Nutrien 4Q EPS $1.18 >NTR.T

18 Feb 2026, 22:37 UTC

Earnings

Nutrien 4Q Sales $5.34B >NTR.T

18 Feb 2026, 22:35 UTC

Earnings

Pan American Silver 4Q EPS $1.07 >PAAS

18 Feb 2026, 22:35 UTC

Earnings

Pan American Silver 4Q Rev $1.18B >PAAS

18 Feb 2026, 22:30 UTC

Earnings

Kinross Gold Raises Quarterly Dividend to 4c Vs. 3.5c >K.T

18 Feb 2026, 22:29 UTC

Earnings

Kinross Gold 4Q EPS 75c >K.T

18 Feb 2026, 22:22 UTC

Earnings

Coeur Mining: Full-Yr 2026 Production Is Expected to Be 55,000 - 65,000 Ounces of Gold and 5.5M - 6.3M Ounces of Silver >CDE

18 Feb 2026, 22:22 UTC

Market Talk

Nvidia 4Q Earnings Coming Amid China Export Battle -- Market Talk

18 Feb 2026, 22:16 UTC

Earnings

Brambles Raises Dividend, Cash-Flow Guidance as 1H Profit Jumps -- Update

18 Feb 2026, 22:05 UTC

Earnings

Pan American Silver Reports Record Fourth Quarter And Full Year 2025 Financial Results; Record Cash Flow From Operations Of $554 Million In The Fourth Quarter; Dividend Increased By 29% >PAAS

18 Feb 2026, 22:03 UTC

Earnings

Kaiser Aluminum Expects to Improve Conversion Rev by 5% to 10% and Adj EBITDA by 5% to 15% for FY26 >KALU

18 Feb 2026, 22:02 UTC

Earnings

Kaiser Aluminum 4Q Adj EPS $1.53 >KALU

18 Feb 2026, 22:02 UTC

Earnings

Kaiser Aluminum 4Q Sales $929M >KALU

18 Feb 2026, 22:02 UTC

Earnings

Kaiser Aluminum 4Q EPS $1.68 >KALU

18 Feb 2026, 22:00 UTC

Earnings

Kinross Gold 4Q Adj EPS 67c >KGC

18 Feb 2026, 22:00 UTC

Earnings

Kinross Gold 4Q Sales $2.02B >KGC

18 Feb 2026, 21:56 UTC

Earnings

Wesfarmers Boosts Dividend After 1H Profit Rises -- Update

18 Feb 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

Peer Comparison

Price change

Evolent Health Inc Forecast

Price Target

By TipRanks

187.77% upside

12 Months Forecast

Average 8 USD  187.77%

High 10 USD

Low 5 USD

Based on 7 Wall Street analysts offering 12 month price targets forEvolent Health Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

7 ratings

6

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

10.33 / 10.95Support & Resistance

Short Term

Very Strong Bullish Evidence

Intermediate Term

Very Strong Bullish Evidence

Long Term

Weak Bearish Evidence

Sentiment

By Acuity

309 / 351 Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
help-icon Live chat